PYRUKYND
Live / Registered — Registered (as of 23 Mar 2021)
What this means for you
Registered since 23 Mar 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88514664
- Registration number
- 6302036
- Mark type
- Stylized text
- Filed
- 15 Jul 2019
- Published for opposition
- 05 Nov 2019
- Registered
- 23 Mar 2021
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of sickle cell disease, PKD and beta thalassemia; pharmaceutical products for the prevention and treatment of rare genetic diseases effecting red blood cells; pharmaceutical products for the prevention and treatment of various anemias
Owner
- Agios Pharmaceuticals, Inc., Cambridge, MA, US
- Agios Pharmaceuticals, Inc., Cambridge, MA, US
- Agios Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 23 Mar 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Feb 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Feb 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Feb 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Feb 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Feb 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Mar 2021 — REGISTERED-PRINCIPAL REGISTER
- 19 Feb 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Feb 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Feb 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Jan 2021 — USE AMENDMENT FILED
- 11 Feb 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Jan 2021 — TEAS STATEMENT OF USE RECEIVED
- 19 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2020 — SOU EXTENSION 2 GRANTED